Nut consumption and metabolic syndrome in US adolescents.
Public Health Nutr. 2018 Dec;21(17):3245-3252. doi: 10.1017/S1368980018002070
Kim RJ1, Wang L1, Worley S1, Leonard D2.
1 Cleveland Clinic Children's Hospital,9500 Euclid Avenue/A120, Cleveland,OH 44195,USA.
2 Children's Health,1935 Medical District, Dallas,TX,USA.
Items in both categories Metabolic Syndrome and Magnesium are listed here:
- Diabetes, Metabolic Syndrome and Magnesium - many studies
- Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes - Jan 2021
- The Role of Magnesium in the Pathogenesis of Metabolic Disorders – April 2022
- Metabolic Syndrome risk reduced 3.7 X by nuts (Magnesium, Omega-3) – Dec 2018
- Magnesium in Healthcare (Rickets, Stones, Pregnancy, Depression, etc.) with level of evidence – Sept 2017
- Metabolic Syndrome treatment by vitamin D probably helped by Vitamin A, Zinc, and Magnesium – July 2016
- More vitamin D makes for better health – dissertation based on Rotterdam studies – Oct 2015
- Metabolic Syndrome risk decreases 12 percent with 150 mg of Magnesium – meta-analysis Dec 2014
- Daily Magnesium improved all aspects of metabolic profile – RCT July 2014
Items in both categories Metabolic Syndrome and Omega-3 are listed here:
- Metabolic Syndrome risk reduced 3.7 X by nuts (Magnesium, Omega-3) – Dec 2018
- Pancreatic Cancer is increasing – Vitamin D and Omega-3 should reduce the risk
- How Omega-3 fights metabolic syndrome and weight – Feb 2018
- Obese youths 2X less likely to develop Metabolic Syndrome if take Omega-3 – RCT April 2016
OBJECTIVE: To determine whether nut intake is associated with the prevalence of metabolic syndrome in US adolescents.
DESIGN: A cross-sectional analysis of data from the National Health and Nutrition Examination Survey (NHANES) years 2003-2012. Anthropometric measurements, blood tests, 24 h diet recalls and demographic data were retrieved for participating adolescents. Metabolic syndrome was defined according to paediatric-modified Adult Treatment Panel III criteria. The exposure was defined as a nut intake ≥5 g/d.
SETTING: USA.
SUBJECTS: Individuals aged 12-19 years (n 2805).
RESULTS:
Nut consumption was associated with lower odds for metabolic syndrome (crude OR=0·25; 95 % CI 0·11, 0·55; P≤0·001). This effect was independent of age, sex, race/ethnicity and family income:poverty ratio (adjusted OR=0·27; 95 % CI 0·12, 0·61; P=0·002), and was stable after controlling for nutritional covariates including intake of sugar and total energy consumption (OR=0·36; 95 % CI 0·16, 0·81; P=0·014).
CONCLUSION: Nut consumption of ≥5 g/d is independently associated with lower odds for metabolic syndrome in US adolescents.